Pharmacological interventions for the correction of ion transport defect in cystic fibrosis

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.10, 2004-10, pp. : 1465-1483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological treatment of the ion transport defect in cystic fibrosis

By Roomans G.M.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 1, 2001-01 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function

Current Drug Targets, Vol. 17, Iss. 11, 2016-07 ,pp. : 1275-1281

Bentham Science Publishers

Access to resources Recommend Favorite

PDE5 inhibitors for cystic fibrosis: can they also enhance chloride transport?

By Antoniu Sabina A

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 965-968

Informa Healthcare

Access to resources Recommend Favorite

Drug Disposition in Cystic Fibrosis

By Rey E. Tréluyer J-M. Pons G.

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 313-329

Adis International

Access to resources Recommend Favorite

Nebulized Antibiotics in Cystic Fibrosis

By Sermetgaudelus I.

Pediatric Drugs, Vol. 4, Iss. 7, 2002-01 ,pp. : 455-467

Adis International

Access to resources Recommend Favorite